Phacilitate Leaders Forum

29TH - 30TH SEPTEMBER 2020



Shree Patel

Shree Patel

Vice President Clinical Operations, Achilles Therapeutics

Shree serves as VP Clinical Operations at Achilles and has worked in the cell therapy field for 10 years. Shree has experience in the set up and implementation of supply chain for procurement and delivery of clinical/commercial cell therapy products in transplant and oncology. Previously, she was responsible for set up, project management and delivery of early and late stage cell therapy clinical trials in paediatric and adult populations, predominantly with virus specific T cells in autologous and allogeneic settings with additional work on product management for new oncology cell therapy candidates. She also supported set up and conduct of global early phase oncology cell therapy trials.   Shree has a PhD in Structural Biochemistry from UCL, MSc Bioinformatics from Imperial and BSc Genetics from UCL.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd